NCT06206902 2024-02-23
F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Shanghai Simnova Biotechnology Co.,Ltd.
Phase 1 Unknown
Clinical Trials
9 trialsNCT04894825 2023-11-27
Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Phase 1 Unknown
NCT04836871 2023-07-13
Double Filtration Plasmapheresis Combined With Chemotherapy
Zhongnan Hospital
Phase 1 Unknown
NCT05273814 2022-07-13
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown
NCT04990063 2021-08-04
Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)
Tang-Du Hospital
Phase 1 Unknown
NCT03308604 2021-07-07
NANOCOL
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Unknown
NCT04229537 2020-01-18
Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC
Sinocelltech Ltd.
Phase 1 Unknown
NCT03971214 2019-06-04
PICARES
ChineseAMS
Phase 1 Unknown
NCT03563326 2018-09-17
Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)
West China Hospital
Phase 1 Unknown